Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors | Zendy

Klaudia Sapko | Zendy; Anna Jamróz-Wiśniewska | Zendy; Michał Marciniec | Zendy; Marcin Kulczyński | Zendy; Anna Szczepańska-Szerej | Zendy; Konrad Rejdak | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors

Author(s) -

Klaudia Sapko,

Anna Jamróz-Wiśniewska,

Michał Marciniec,

Marcin Kulczyński,

Anna Szczepańska-Szerej,

Konrad Rejdak

Publication year - 2020

Publication title -

neurologia i neurochirurgia polska

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.484

H-Index - 26

eISSN - 1897-4260

pISSN - 0028-3843

DOI - 10.5603/pjnns.a2020.0037

Subject(s) - medicine , multiple sclerosis , disease , cerebrospinal fluid , magnetic resonance imaging , stage (stratigraphy) , clinical practice , intensive care medicine , pathology , physical therapy , immunology , radiology , paleontology , biology

Multiple Sclerosis (MS) is a chronic, demyelinating disease of the central nervous system which affects mostly young people. Because it leads to disability and cognitive impairment, it is crucial to recognise MS at an early stage.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research